More Patients Requesting Juvederm Voluma XC

Published on January 28, 2014

Following its approval by the FDA, board-certified Los Angeles cosmetic surgeon Dr. Robert Abergel says that he’s seen a surge in the number of his patients who are requesting Juvederm Voluma XC to add volume to their cheeks.

Word has apparently spread pretty quickly regarding the effectiveness of Voluma XC. The dermal filler earned its FDA approval last October and became available to Los Angeles plastic surgeons and dermatologists in December 2013. Dr. Abergel says it’s impressive how quickly the news has spread and added that it’s a testimony to how good the results of the treatment really are.

So what is Juvederm Voluma XC?
Juvederm Voluma XC is an injectable gel made of a natural substance called hyaluronic acid, which helps to keep skin firm and hydrated. It’s the first injectable that has been approved to plump the cheeks, and results from just one 30-minute treatment can last as long as 2 years.

Losing volume in the cheeks is a common sign of age, leaving them looking flat or sunken. In recent years, researchers have worked to develop ways to restore that volume, and Juvederm Voluma XC is a result of their work.

And while Botox has taken over the market for smoothing wrinkles around the eyes, Voluma XC appears to be its equivalent for the cheeks.

Los Angeles cosmetic surgeon Dr. Abergel also says that this filler can be used for people of a wide range of ages and different skin types and that it can also be used in combination with plastic surgery.

Wonders of Juvederm Voluma XC
Facelift patients, in particular, often choose injectables and other non-surgical treatments to extend their results, and VOLUMA XC will work well for these patients and for anyone else who wants their cheeks to look more youthful by way of a quick, convenient treatment.

If you are interested in learning more about the effectiveness of Juvederm Voluma XC call the office of Los Angeles cosmetic surgeon Dr. Robert Abergel today to schedule an appointment.

Filed under: , , , ,